Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).

Autor: Reichert ZR; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA., Kasputis T; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA., Nallandhighal S; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA., Abusamra SM; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA., Kasputis A; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA., Haruray S; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA., Wang Y; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA., Williams S; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA., Singhal U; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.; Department of Urology, Mayo Clinic, Rochester, MN 55901, USA., Alva A; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, Ann Arbor, MI 48109, USA., Cackowski FC; Division of Medical Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA., Caram MEV; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA., Palmbos PL; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA., Yentz SE; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Lieutenant Colonel Charles S. Kettles VA Medical Center, Ann Arbor, MI 48105, USA., Smith DC; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA., Alumkal JJ; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA., Morgan TM; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2021 Dec 21; Vol. 23 (1). Date of Electronic Publication: 2021 Dec 21.

Implementation of a Multidisciplinary Care Pathway via an Emergency Department-ICU to Improve Care of Emergency Department Patients Presenting With Leukostasis.

Autor: Haas NL; Department of Emergency Medicine, University of Michigan, Ann Arbor, MI.; Department of Emergency Medicine, Division of Critical Care, University of Michigan, Ann Arbor, MI., Nafday A; Department of Emergency Medicine, University of Michigan, Ann Arbor, MI., Cranford JA; Department of Emergency Medicine, University of Michigan, Ann Arbor, MI., Yentz SE; Department of Internal Medicine, Division of Hematology and Medical Oncology, University of Michigan, Ann Arbor, MI., Bixby DL; Department of Internal Medicine, Division of Hematology and Medical Oncology, University of Michigan, Ann Arbor, MI., Bassin BS; Department of Emergency Medicine, University of Michigan, Ann Arbor, MI.; Department of Emergency Medicine, Division of Critical Care, University of Michigan, Ann Arbor, MI.; Michigan Center for Integrative Research in Critical Care, University of Michigan, Ann Arbor, MI.

Publikováno v: Critical care explorations [Crit Care Explor] 2020 Feb 24; Vol. 2 (2), pp. e0084. Date of Electronic Publication: 2020 Feb 24 (Print Publication: 2020).

Targeted randomization dose optimization trials enable fractional dosing of scarce drugs.

Autor: Boonstra, Philip S.^1,2 (AUTHOR), Tabarrok, Alex³ (AUTHOR), Strohbehn, Garth W.^2,4,5,6,7 (AUTHOR) gstrohbe@umich.edu

Publikováno v: PLoS ONE. 10/30/2023, Vol. 18 Issue 10, p1-16. 16p.

Bevacizumab in advanced NSCLC: chemotherapy partners and duration of use.

Autor: Gentzler RD; Division of Hematology/Oncology, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 676 North St. Clair, Suite 850, Chicago, IL, 60611, USA., Yentz SE, Patel JD

Publikováno v: Current treatment options in oncology [Curr Treat Options Oncol] 2013 Dec; Vol. 14 (4), pp. 595-609.

The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021.

Autor: Ascierto, Paolo A.¹ (AUTHOR) paolo.ascierto@gmail.com, Warner, Allison Betof² (AUTHOR), Blank, Christian³ (AUTHOR), Caracò, Corrado⁴ (AUTHOR), Demaria, Sandra⁵ (AUTHOR), Gershenwald, Jeffrey E.⁶ (AUTHOR), Khushalani, Nikhil I.⁷ (AUTHOR), Long, Georgina V.^8,9,10,11 (AUTHOR), Luke, Jason J.¹² (AUTHOR), Mehnert, Janice M.¹³ (AUTHOR), Robert, Caroline¹⁴ (AUTHOR), Rutkowski, Piotr¹⁵ (AUTHOR), Tawbi, Hussein A.¹⁶ (AUTHOR), Osman, Iman¹⁷ (AUTHOR), Puzanov, Igor¹⁸ (AUTHOR)

Publikováno v: Journal of Translational Medicine. 5/10/2022, Vol. 20 Issue 1, p1-20. 20p.